239 related articles for article (PubMed ID: 21964253)
1. Adenosine A2a receptor antagonists attenuate striatal adaptations following dopamine depletion.
Peterson JD; Goldberg JA; Surmeier DJ
Neurobiol Dis; 2012 Jan; 45(1):409-16. PubMed ID: 21964253
[TBL] [Abstract][Full Text] [Related]
2. A2A adenosine receptor antagonism enhances synaptic and motor effects of cocaine via CB1 cannabinoid receptor activation.
Tozzi A; de Iure A; Marsili V; Romano R; Tantucci M; Di Filippo M; Costa C; Napolitano F; Mercuri NB; Borsini F; Giampà C; Fusco FR; Picconi B; Usiello A; Calabresi P
PLoS One; 2012; 7(6):e38312. PubMed ID: 22715379
[TBL] [Abstract][Full Text] [Related]
3. Adenosine A
Nunes ACL; Carmo M; Behrenswerth A; Canas PM; Agostinho P; Cunha RA
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732120
[TBL] [Abstract][Full Text] [Related]
4. Motor Deficits Coupled to Cerebellar and Striatal Alterations in Ube3a
Moreira-de-Sá A; Gonçalves FQ; Lopes JP; Silva HB; Tomé ÂR; Cunha RA; Canas PM
Mol Neurobiol; 2021 Jun; 58(6):2543-2557. PubMed ID: 33464534
[TBL] [Abstract][Full Text] [Related]
5. Caffeine and a selective adenosine A2A receptor antagonist induce sensitization and cross-sensitization behavior associated with increased striatal dopamine in mice.
Hsu CW; Wang CS; Chiu TH
J Biomed Sci; 2010 Jan; 17(1):4. PubMed ID: 20074377
[TBL] [Abstract][Full Text] [Related]
6. Modulation of GABAergic transmission in the striatopallidal system by adenosine A2A receptors: a potential mechanism for the antiparkinsonian effects of A2A antagonists.
Mori A; Shindou T
Neurology; 2003 Dec; 61(11 Suppl 6):S44-8. PubMed ID: 14663009
[TBL] [Abstract][Full Text] [Related]
7. Enhanced ATP release and CD73-mediated adenosine formation sustain adenosine A
Carmo M; Gonçalves FQ; Canas PM; Oses JP; Fernandes FD; Duarte FV; Palmeira CM; Tomé AR; Agostinho P; Andrade GM; Cunha RA
Br J Pharmacol; 2019 Sep; 176(18):3666-3680. PubMed ID: 31220343
[TBL] [Abstract][Full Text] [Related]
8. The distinct role of medium spiny neurons and cholinergic interneurons in the D₂/A₂A receptor interaction in the striatum: implications for Parkinson's disease.
Tozzi A; de Iure A; Di Filippo M; Tantucci M; Costa C; Borsini F; Ghiglieri V; Giampà C; Fusco FR; Picconi B; Calabresi P
J Neurosci; 2011 Feb; 31(5):1850-62. PubMed ID: 21289195
[TBL] [Abstract][Full Text] [Related]
9. Functional interaction between pre-synaptic α6β2-containing nicotinic and adenosine A2A receptors in the control of dopamine release in the rat striatum.
Garção P; Szabó EC; Wopereis S; Castro AA; Tomé ÂR; Prediger RD; Cunha RA; Agostinho P; Köfalvi A
Br J Pharmacol; 2013 Aug; 169(7):1600-11. PubMed ID: 23638679
[TBL] [Abstract][Full Text] [Related]
10. Genetic deletion of GPR52 enhances the locomotor-stimulating effect of an adenosine A
Nishiyama K; Suzuki H; Maruyama M; Yoshihara T; Ohta H
Brain Res; 2017 Sep; 1670():24-31. PubMed ID: 28583861
[TBL] [Abstract][Full Text] [Related]
11. Behavioral control by striatal adenosine A
Taura J; Valle-León M; Sahlholm K; Watanabe M; Van Craenenbroeck K; Fernández-Dueñas V; Ferré S; Ciruela F
Genes Brain Behav; 2018 Apr; 17(4):e12432. PubMed ID: 29053217
[TBL] [Abstract][Full Text] [Related]
12. Progress in pursuit of therapeutic A2A antagonists: the adenosine A2A receptor selective antagonist KW6002: research and development toward a novel nondopaminergic therapy for Parkinson's disease.
Kase H; Aoyama S; Ichimura M; Ikeda K; Ishii A; Kanda T; Koga K; Koike N; Kurokawa M; Kuwana Y; Mori A; Nakamura J; Nonaka H; Ochi M; Saki M; Shimada J; Shindou T; Shiozaki S; Suzuki F; Takeda M; Yanagawa K; Richardson PJ; Jenner P; Bedard P; Borrelli E; Hauser RA; Chase TN;
Neurology; 2003 Dec; 61(11 Suppl 6):S97-100. PubMed ID: 14663020
[TBL] [Abstract][Full Text] [Related]
13. Adenosine A2A receptor contributes to ischemic brain damage in newborn piglet.
Yang ZJ; Wang B; Kwansa H; Heitmiller KD; Hong G; Carter EL; Jamrogowicz JL; Larson AC; Martin LJ; Koehler RC
J Cereb Blood Flow Metab; 2013 Oct; 33(10):1612-20. PubMed ID: 23860373
[TBL] [Abstract][Full Text] [Related]
14. Striatal plasticity at the network level. Focus on adenosine A2A and D2 interactions in models of Parkinson's Disease.
Tanganelli S; Sandager Nielsen K; Ferraro L; Antonelli T; Kehr J; Franco R; Ferré S; Agnati LF; Fuxe K; Scheel-Krüger J
Parkinsonism Relat Disord; 2004 Jul; 10(5):273-80. PubMed ID: 15196505
[TBL] [Abstract][Full Text] [Related]
15. Selective A
Bortolatto CF; Reis AS; Pinz MP; Voss GT; Oliveira RL; Vogt AG; Roman S; Jesse CR; Luchese C; Wilhelm EA
Metab Brain Dis; 2017 Dec; 32(6):1919-1927. PubMed ID: 28795281
[TBL] [Abstract][Full Text] [Related]
16. JNJ-40255293, a novel adenosine A2A/A1 antagonist with efficacy in preclinical models of Parkinson's disease.
Atack JR; Shook BC; Rassnick S; Jackson PF; Rhodes K; Drinkenburg WH; Ahnaou A; Te Riele P; Langlois X; Hrupka B; De Haes P; Hendrickx H; Aerts N; Hens K; Wellens A; Vermeire J; Megens AA
ACS Chem Neurosci; 2014 Oct; 5(10):1005-19. PubMed ID: 25203719
[TBL] [Abstract][Full Text] [Related]
17. Effects of the selective adenosine A2A receptor antagonist, SCH 412348, on the parkinsonian phenotype of MitoPark mice.
Smith KM; Browne SE; Jayaraman S; Bleickardt CJ; Hodge LM; Lis E; Yao L; Rittle SL; Innocent N; Mullins DE; Boykow G; Reynolds IJ; Hill D; Parker EM; Hodgson RA
Eur J Pharmacol; 2014 Apr; 728():31-8. PubMed ID: 24486705
[TBL] [Abstract][Full Text] [Related]
18. Effects of adenosine receptor antagonists on the in vivo LPS-induced inflammation model of Parkinson's disease.
Gołembiowska K; Wardas J; Noworyta-Sokołowska K; Kamińska K; Górska A
Neurotox Res; 2013 Jul; 24(1):29-40. PubMed ID: 23296550
[TBL] [Abstract][Full Text] [Related]
19. Adenosine Receptor Modulation of Hypoxic-ischemic Injury in Striatum of Newborn Piglets.
Ortega-Gutierrez S; Jones B; Mendez-Ruiz A; Shah P; Torbey MT
Curr Neurovasc Res; 2020; 17(4):510-517. PubMed ID: 32867657
[TBL] [Abstract][Full Text] [Related]
20. Anatomy of adenosine A2A receptors in brain: morphological substrates for integration of striatal function.
Rosin DL; Hettinger BD; Lee A; Linden J
Neurology; 2003 Dec; 61(11 Suppl 6):S12-8. PubMed ID: 14663003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
